Phase I Oncology Clinical Research

Piper Companies is seeking a Phase I Oncology Clinical Research Associate to support early-phase oncology clinical trials within the biotechnology and pharmaceutical industry. The Phase I Oncology Clinical Research Associate role is ideal for a clinical research professional experienced with first-in-human and dose-escalation oncology studies. The Phase I Oncology Clinical Research Associate role is a remote opportunity and requires you to travel up to 8-10 days per month.
Responsibilities of the Phase I Oncology Clinical Research Associate:
Monitor Phase I and first-in-human oncology trials in compliance with ICH-GCP and FDA regulations.
Conduct site initiation, monitoring, and close-out visits.
Ensure subject safety, data quality, and protocol adherence.
Review source documents, EDC data, and safety reports.
Collaborate with sites and internal clinical teams to resolve issues.
Requirements of the Phase I Oncology Clinical Research Associate:
3+ years of onsite monitoring as a CRA with a focus on Phase I or early-phase oncology.
Bachelors Degree is Required
Hands-on experience with dose-escalation and DLTs.
Strong knowledge of GCP, FDA regulations, and monitoring best practices.
Experience with oncology indications and EDC systems.
Ability to travel to research sites as required.
Compensation for the Phase I Oncology Clinical Research Associate:
$110,000 - $140,000 base salary
Full Comprehensive Benefits: Health, Vision, Dental, PTO, Paid Holiday and Sick Leave if Required by Law.
Keywords: Phase One Oncology CRA, Clinical Research Associate, Phase I Oncology, First-in-Human Trials, Dose Escalation, Oncology Clinical Research, GCP, FDA Regulations, Clinical Monitoring, Biotechnology, Pharmaceutical
This job opens for applications on 11/13/2026. Applications for this job will be accepted for at least 30 days from the posting date.
#REMOTE